Insider Transactions in Q2 2021 at Arcutis Biotherapeutics, Inc. (ARQT)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
6,755
-0.8%
|
$182,385
$27.5 P/Share
|
|
Jun 24
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
729
-0.09%
|
$19,683
$27.5 P/Share
|
|
Jun 21
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
2,516
-0.3%
|
$67,932
$27.5 P/Share
|
|
Jun 18
2021
|
Todd Franklin Watanabe Director |
BUY
Other acquisition or disposition
|
Indirect |
7,377
+11.4%
|
-
|
|
Jun 07
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,750
-0.29%
|
$45,500
$26.35 P/Share
|
|
Jun 07
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+0.29%
|
$1,750
$1.68 P/Share
|
|
Jun 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,200
-0.51%
|
$59,400
$27.34 P/Share
|
|
Jun 01
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+0.34%
|
$6,600
$3.29 P/Share
|
|
Jun 01
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
10,000
-1.16%
|
$270,000
$27.5 P/Share
|
|
May 21
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,612
+0.38%
|
$1,612
$1.13 P/Share
|
|
May 10
2021
|
Frazier Life Sciences Viii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
96,574
-100.0%
|
-
|
|
May 10
2021
|
Frazier Life Sciences Viii, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
96,574
+50.0%
|
-
|
|
May 10
2021
|
Frazier Life Sciences Viii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
2,108,558
-20.0%
|
-
|
|
May 07
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
750
-0.13%
|
$26,250
$35.0 P/Share
|
|
May 07
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+0.13%
|
$750
$1.68 P/Share
|
|
May 05
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,750
-0.29%
|
$59,500
$34.0 P/Share
|
|
May 05
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,607
+0.27%
|
$1,607
$1.68 P/Share
|
|
May 03
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,200
-0.52%
|
$74,800
$34.84 P/Share
|
|
May 03
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+0.34%
|
$6,600
$3.29 P/Share
|
|
Apr 30
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,500
-0.25%
|
$52,500
$35.0 P/Share
|
|
Apr 20
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
10,000
-0.57%
|
$280,000
$28.26 P/Share
|
|
Apr 16
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,655
+0.42%
|
$2,655
$1.31 P/Share
|
|
Apr 05
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,750
-0.29%
|
$50,750
$29.93 P/Share
|
|
Apr 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,200
-0.52%
|
$63,800
$29.5 P/Share
|
|
Apr 01
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+0.35%
|
$6,600
$3.29 P/Share
|